NHS England | April 2018 | Heart patients among those to benefit as NHS England backs innovation
A scheme run by NHS England to identify and fast track specific innovations into the NHS is now in its second year. It delivers improvements in patient care by cutting bureaucracy for clinicians and other innovators and encouraging uptake through the NHS. NHS England has just announced four innovations that have the potential to benefit patients. Among the innovations is image analysis software that creates a 3D model of the heart and could prevent up to 35,000 patients a year undergoing invasive tests. Other innovations identified include a suture which is designed to reduce infections, a new device that will reduce the number of infections from catheters and a ‘bowel scope’ to improve colorectal examinations.
- HeartFlow – Advanced image analysis software that creates a 3D model of the coronary arteries and analyses the impact that blockages have on blood flow to rapidly diagnose patients with suspected coronary artery disease. The use of the device can avoid the need for invasive investigations such as coronary angiography, usually carried out under local anaesthetic, where a catheter is passed through the blood vessels to the heart to release a dye before X-rays are taken. NICE estimate up to 35,000 people per year could be eligible.
- Plus Sutures – A new type of surgical suture – stitching – that reduces the rate of surgery-linked infection (surgical site infection) such as MRSA, through the use of antimicrobial suture packs. There were 823 cases of MRSA reported in the NHS in 2016/17.
- Endocuff Vision – A new type of ‘bowel scope’ that improves colorectal examination for patients undergoing bowel cancer tests. Bowel cancer is the fourth most common cancer in England with 34,000 people diagnosed each year. For every 1,000 people screened for cancer, it is estimated that six cases could be avoided thanks to early detection through the use of this device.
- SecurAcath – A device to secure catheters that reduces the infection risk for patients with a peripherally inserted central catheter. The use of this equipment helps to reduce the time taken to care and treat dressing changes. This type of catheter is normally used in people needing intravenous access for several weeks or months in both inpatient and outpatient settings. NICE estimate up to 120,000 people per year could be eligible.
Professor Tony Young, National Clinical Lead for Innovation at NHS England, said: “For new innovations to flourish and spread at scale access to funding is critical, by buying these four innovations centrally NHS England has removed the barriers to the spread of these innovations so patients can benefit faster.
The NHS’ 15 Academic Health Science Networks across England – will take direct responsibility for accelerating uptake locally.
All information from NHS England, the news release can be read on this webpage